Modal Container (Shows only in EE)
Modal ID: #cookie-management-modal
Open Modal
Close Modal

-

REPORT

Medicines in Development for Immuno-Oncology 2017 Report

Microscopic view of cancer cells

America’s biopharmaceutical research companies are developing more than 240 immuno-oncology treatments.

Interested in reading more on Medicines in Development for Immuno-Oncology 2017 Report?

Get your free copy of the report now.

87%

OF CANCER DIAGNOSES

in the U.S. are people age 50 and older

4.8%+

OF U.S. POPULATION

are cancer survivors

600K

U.S. CANCER DEATHS

were estimated in 2017

1.6M+

NEW CASES OF CANCER

estimated in 2017

Related Resources

Graphic of a piece of paper showing circles and text-like objects

List of Immuno-Oncology Medicines in Development

Read More
The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry

More than 240 immuno-oncology treatments in development to fight cancer

Read More

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.